Gartner Security and Risk Summit 2016 -- Fasoo, Inc., the leader in Data and Software Security, today released the results of the security industry's first look at organizations' confidence around...

Sanofi announced today the presentation of the results of the pivotal Phase 3 LixiLan-O and LixiLan-L clinical trials with the investigational titratable fixed-ratio combination of basal insulin...

New data from a completed Phase 3 trial show Trulicity® (dulaglutide) 1.5 mg significantly reduced hemoglobin A1c (A1C) and body weight as an add-on to insulin glargine without increasing the...

New analyses showed risk reductions were consistent across age groups for cardiovascular (CV) outcomes, including CV death, with Jardiance® (empagliflozin) compared with placebo when added to...

Industry leaders, developers and researchers at the American Diabetes Association's 76th Scientific Sessions are demonstrating how they are tapping into Watson cognitive computing to transform the...